Baricitinib biosimilar and generic competition — the anticipated loss of exclusivity timeline and potential entry of lower-cost baricitinib products — represents the commercial sustainability challenge facing Eli Lilly's baricitinib franchise, with the Baricitinib Market reflecting the long-term market dynamics that generic entry will create for this small molecule JAK...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
English
French
Spanish
Portuguese
Romaian
Portuguese (Brazil)
china